OSMR and esophageal squamous cell carcinoma: Furthermore, while high expression of OSM (94% of patients) was confirmed via IHC, full length OSMRβ was only detected in 23% of patients, suggesting that sOSMRβ may be acting as a neutralizing receptor for OSM in ESCC (203).